Markets
Chip Unveils Rap Star Wax Figures At Madame Tussauds
Wax figures of rap stars Biggie Smalls (aka The Notorious BIG), P Diddy, Tupac Shakur, and Snoop Dogg exhibited for the first time together in London at Madame Tussauds on January 14, 2013, in London, England (Ferdaus Shamim/WireImage)

Why there’s a “huge vibe divergence” between tech and finance on AI

Tech evangelists are hailing a Claude-fueled seismic shift in computer-based work. Investors are, by and large, selling AI stocks.

Not since Biggie Smalls and Tupac has there been an East Coast versus West Coast schism like the current perception gap over artificial intelligence.

The only type of AI exposure that’s worked on Wall Street lately is owning companies benefiting from shortages (memory chips) or ones that will benefit from expanding capacity of these scarce resources (semicap equipment). The theme has been a net negative for the market this year, based on how much software stocks thought to be at risk of severe disintermediation by AI have slumped.

Over in Silicon Valley, commentators and VCs are pounding the table that AI has now proven its ability to transform computer-based work, thanks in large part to recent progress from Anthropic. That is, AI has gotten better at doing things. Things that save us time and have commercial value.

As you might expect given the price action, this apparent discrepancy is primarily being noted by tech types who claim their counterparts in finance are short-sighted and fail to appreciate the scale of recent breakthroughs.


The capabilities of AI that has commercial applications may have increased meaningfully in the past few weeks or months.

But AI is certainly asking a lot more of investors. It’s asking them to forgive a lack of free cash flow generation as money gets piled into massive capex instead of buybacks. And it’s asking them for a lot more money, both through debt issuance in private and public markets and, soon, a heck of a lot of equity supply from the likes of SpaceX/xAI, Anthropic, and OpenAI. The valuations of these privately held companies have increased by about $550 billion since September. Think of it as adding about half a Berkshire Hathaway’s worth of value in five months. 

It would be somewhat disingenuous for AI boosters to say that all these privatized tech gains, and the underlying progress upon which they’re based, wouldn’t also be someone’s pain.

New technology can make old things obsolete. You’re reading this over the internet, not via a fax machine. You watch movies on Netflix, you don’t rent them at Blockbuster. The history of technological innovation has been that it produces net gains over time, but also localized losses.

However, this week, Nvidia CEO Jensen Huang called the idea that the software industry would be replaced by AI the “most illogical thing in the world,” arguing that AI agents will leverage existing software tools rather than reinvent them. A humanoid robot with artificial general intelligence would use an existing chainsaw, not invent a new chainsaw, Huang said as part of an extended analogy that made me want to invest in a Kevlar suit.

Well! I look at the above slide from OpenAI and say, AI “coworkers” are definitely trying to position themselves as being the brains of the operation that drive the core value currently provided by software companies. Whether software companies can extract a reasonable rent from AI “coworkers” for interacting with these systems of record is an open question. If the rent proves to be too damn high, however, that would seemingly raise the appeal of reinventing software tools, rather than working within the existing suite. 

(While I’ve been skeptical that AI is the proximate cause of job losses stateside, I would not be shocked if the substantial drawdown in software stocks is what catalyzes the first major identifiable wave of AI-fueled unemployment.)

But the cause of the divide between tech and finance isn’t simply a matter of how badly software stocks are getting crushed.

It’s reflected in the fact that the hyperscalers, the companies aggressively participating in this arms race, aren’t being treated like there’s a massive war on the horizon that they’re about to collectively win.

By and large, higher-than-expected capex has not been rewarded this season (see: Google, Microsoft, Amazon). Investors seem to be saying that if there are extrapolative expectations and an AI bubble at hand, it’s based on what tech companies are spending, not what they’re willing to pay for them.

Some of the divide between New York and Silicon Valley, in my view, reflects what happens when people veer outside their lane, which can lead to people talking past each other. Assessing the long-term potential utility of recent AI breakthroughs, for instance, is very much outside my lane. 

But make no mistake about it — there is a divide, it’s real, and it’s not easy to answer who’s right and who’s wrong, or how much the truth (likely) is somewhere in the middle.

Some things I think I know that may shed some light on why this tech/finance gap exists, and how it might prove vexing to definitively resolve:

  • Not every great company is a great stock where it’s priced, and not every great stock is a great stock all the time. All the Magnificent 7 hyperscalers outside of Microsoft are outpacing the S&P 500 since the unofficial launch party of the AI boom in 2023.

    • Zooming out, tech insiders are lauding the increasing promise of AI, and investors are ascribing more value to the top model providers and the companies spending the most on compute. 

  • My ability to use AI to augment my work has increased exponentially since mid-November.

  • The hangover from capex binges tends to be a very difficult period for the big spenders (see: aftermath of shale investment or dot-com bubble) — and that’s not an indictment of the technology.

  • If AI is a flop in ROI terms, it would not be the first time Silicon Valley vastly overestimated the commercial, real-world applicability of a new technology.

  • In the short term, initial conditions and positioning matter more than fundamentals in explaining price action. And financial market narratives will follow price.

If tech bros and finance bros have one thing in common (besides vests), it’s an affinity for riding hot trends. AI’s ability to complete long tasks faster than humans is seemingly accelerating; AI stocks, by and large, have had a rough 2026. 

So if both groups allow lines to determine narratives and those lines point in different directions, it’s no wonder they’re living in different worlds.

More Markets

See all Markets
markets

FDA says it will take “decisive steps” against GLP-1 compounders, HHS refers Hims to DOJ for investigation

The Food and Drug Administration said it would take "decisive steps" to restrict GLP-1 compounding, a day after Hims & Hers announced that it would sell copies ofNovo Nordisk’sWegovy pill.

The FDA specifically called out Hims in the announcement. Additionally Department of Health and Human Services' General Counsel Mike Stuart said in a post on X on Friday he has referred Hims to the Department of Justice "for investigation for potential violations by Hims of the Federal Food, Drug, and Cosmetic Act and applicable Title 18 provisions."

This marks a significant shift in tone from the FDA, which has done little to prevent companies like Hims from marketing copies of Novo's lucrative weight loss drugs.

Shares of Hims fell 14% after hours. The stock had already taken a hit after FDA Commissioner Marty Makary said in an X post on Thursday that the agency would “take swift action against companies mass-marketing illegal copycat drugs.”

The FDA specifically called out Hims in the announcement. Additionally Department of Health and Human Services' General Counsel Mike Stuart said in a post on X on Friday he has referred Hims to the Department of Justice "for investigation for potential violations by Hims of the Federal Food, Drug, and Cosmetic Act and applicable Title 18 provisions."

This marks a significant shift in tone from the FDA, which has done little to prevent companies like Hims from marketing copies of Novo's lucrative weight loss drugs.

Shares of Hims fell 14% after hours. The stock had already taken a hit after FDA Commissioner Marty Makary said in an X post on Thursday that the agency would “take swift action against companies mass-marketing illegal copycat drugs.”

Airlines rise, continuing their volatile 2026, as US-Iran talks may foreshadow some oil supply relief

Airline stocks are surging on Friday, as the market appears to be pricing in some medium-term oil pricing relief following talks between the US and Iran. Iranian officials referred to the meeting as “a good beginning.”

Shares of budget carriers, which have tighter margins and are more sensitive to fluctuations in fuel costs, are leading the surge. Frontier Airlines and Allegiant up more than 13%, while major airlines like United Airlines, American Airlines, and Delta Air Lines are also up at least 6%. JetBlue and Alaska Air are similarly up about 6%.

The market more broadly is rebounding on Friday, with the S&P 500 up 1.6% and bitcoin recovering some of this week’s losses.

Airlines have been volatile to start 2026 amid geopolitical tensions, varying annual forecasts, and the impact of winter storms.

markets

The AI supply chain is soaring thanks to Amazon’s capex budget

If tech companies are going to spend way more than expected on capex, well, that means other companies are poised to benefit from that massive spending spree.

Amazon’s plan for $200 billion in business investment this year was the exclamation point to end a reporting period that saw every Magnificent 7 hyperscaler that provides guidance offer a 2026 capex budget well above what Wall Street had anticipated.

Here’s a look at the different parts of the supply chain that are soaring on the persistent demand for, and seeming scarcity of, AI compute:

Here’s a look at the different parts of the supply chain that are soaring on the persistent demand for, and seeming scarcity of, AI compute:

markets

For memory chips, the “parabolic price hike” is continuing to ramp higher

The remarkable run-up in prices for memory chips continued into early February, analysts at Bernstein Research say, driven largely by data center demand from hyperscalers and cloud service providers (CSP).

Prices for NAND flash memory wafers — a type of memory used in devices, as it retains data even when powered down — soared 35% between the end of 2025 and February 2.

Spot prices for DRAM — ubiquitous short-term data storage chips — jumped about 28% in that period. But that massively understates the remarkable shift in pricing for what were long seen as commodity tech hardware inputs. DRAM prices are more than 2,000% over the last year, while NAND prices are up more than 600% in that period.

The ongoing momentum provides still more support for memory chip plays like Micron and Sandisk, which have been big market winners in recent months.

In a note published earlier this week, Bernstein Research analysts wrote:

“The parabolic price hike continued in Jan. Indicated price increase for 1QCY26 is much stronger than we expected and we hence see upside to our near term memory pricing projection. Unrelenting CSP demand remained the main driver. PC and Mobile demand hasn’t been destroyed yet because of lean inventory & pull-forward purchase. Going forward price hike is expected to continue but likely at a slower rate, as PC and Mobile demand should contract meaningfully this year. Price however may stay elevated throughout this year, supported by CSP demand.”

Latest Stories

Sherwood Media, LLC produces fresh and unique perspectives on topical financial news and is a fully owned subsidiary of Robinhood Markets, Inc., and any views expressed here do not necessarily reflect the views of any other Robinhood affiliate, including Robinhood Markets, Inc., Robinhood Financial LLC, Robinhood Securities, LLC, Robinhood Crypto, LLC, or Robinhood Money, LLC.